Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE

[1]  F. Salvi,et al.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. , 2009, Journal of vascular surgery.

[2]  Jeffrey Bond,et al.  Pertussis toxin induces angiogenesis in brain microvascular endothelial cells , 2008, Journal of neuroscience research.

[3]  M. Gorospe,et al.  JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function. , 2008, Molecular biology of the cell.

[4]  Carola Förster,et al.  Tight junctions and the modulation of barrier function in disease , 2008, Histochemistry and Cell Biology.

[5]  A. Bouthillier,et al.  Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis , 2007, The Journal of Neuroscience.

[6]  L. Rivers,et al.  Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis , 2007, Neuroscience.

[7]  H. Koprowski,et al.  Loss of blood–brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models , 2007, Proceedings of the National Academy of Sciences.

[8]  S. McQuaid,et al.  Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.

[9]  S. McQuaid,et al.  Differences in expression of junctional adhesion molecule-A and β-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology , 2007, Acta Neuropathologica.

[10]  C. Förster,et al.  Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.

[11]  B. Engelhardt,et al.  Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis , 2006, Journal of neuropathology and experimental neurology.

[12]  H. Keirstead,et al.  Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. , 2005, Transplant immunology.

[13]  H. Keirstead,et al.  Stem cells for the treatment of myelin loss , 2005, Trends in Neurosciences.

[14]  L. Bö,et al.  Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes , 2005, Journal of neuropathology and experimental neurology.

[15]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[16]  S. McQuaid,et al.  Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.

[17]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[18]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[19]  E. Oldfield,et al.  Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats , 2002, Journal of neuropathology and experimental neurology.

[20]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[21]  S. McQuaid,et al.  Abnormal Endothelial Tight Junctions in Active Lesions and Normal‐appearing White Matter in Multiple Sclerosis , 2002, Brain pathology.

[22]  K. Turksen,et al.  Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. , 2002, Development.

[23]  Tetsuo Noda,et al.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier , 2002, The Journal of cell biology.

[24]  R. Rudick,et al.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. , 2002, The New England journal of medicine.

[25]  R. Sobel,et al.  White Matter Extracellular Matrix Chondroitin Sulfate/Dermatan Sulfate Proteoglycans in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[26]  A. Mankertz,et al.  Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. , 2000, Journal of cell science.

[27]  H. Wolburg,et al.  Tight Junctions of the Blood–Brain Barrier , 2000, Cellular and Molecular Neurobiology.

[28]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[29]  R. Lifton,et al.  Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. , 1999, Science.

[30]  P. Dore‐Duffy,et al.  Role of the CNS microvascular pericyte in the blood‐brain barrier , 1998, Journal of neuroscience research.

[31]  D. Paty,et al.  Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor definitive clinical trials. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[32]  R. Sobel.  The Extracellular Matrix in Multiple Sclerosis Lesions , 1998, Journal of neuropathology and experimental neurology.

[33]  B. Gumbiner,et al.  A Synthetic Peptide Corresponding to the Extracellular Domain of Occludin Perturbs the Tight Junction Permeability Barrier , 1997, The Journal of cell biology.

[34]  D. Miller,et al.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.

[35]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[36]  S W Atlas,et al.  Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.

[37]  D. Vivien,et al.  Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier , 2008 .

[38]  M. Balda,et al.  Comment Holey barrier: claudins and the regulation of brain endothelial , 2003 .